Maryanne Trevisan

Maryanne provides strategic legal counseling to her clients relating to patentability, competitive landscape, freedom-to-operate, and enforcement analyses, with an emphasis on aligning IP development, direction and expenditure with client priorities and assets. In addition, she regularly advises on Orange Book listing strategy and supports IP due diligence activity. She has also been involved in several interferences and oppositions.

For her doctoral work, Maryanne studied adult hematopoietic stem cells in the murine model and established that long-term engraftment was the functional gold standard for such cells. For her post-doctoral work, she studied hemopoietic defects in Ikaros knock-out mice using in vitro embryonic stem (ES) cell differentiation assays.

Maryanne’s law school thesis analyzed the antitrust issues in patent litigation settlements between brand name and generic pharmaceutical companies.